News

More than 15 million people across the US, UK, Germany and France are unknowingly living with metabolic ...
The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...
A new study reveals that dapagliflozin, a common diabetes medication, could significantly improve conditions like metabolic ...
Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...
Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...
About 89bio 89bio is a clinical-stage biopharmaceutical company dedicated to the development of best-in-class therapies for patients with liver and cardiometabolic diseases who lack optimal treatment ...
Modern unhealthy lifestyles and dietary habits have led to a yearly increase in the incidence of metabolism-related liver ...
First Installation at Hemas Hospital Wattala DIMO Healthcare, a leader in the Sri Lankan healthcare sector, has introduced ...
Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...
Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...